8. “Imexon for Relapsed Follicular and Aggressive Lymphomas” has already presented some results, but the research being conducted in collaboration between the University of Rochester and the University of Arizona is not completed yet.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?